Loading…
Intelligent Bio Solutions Inc. is projected to decline to $2.03 by 2027, a -6% move from its current price of $2.16. INBS is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/12/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $2.09 | $2.16 | $2.23 | -0.03% |
| Jul 14 | $2.06 | $2.16 | $2.26 | -0.05% |
| Jul 15 | $2.04 | $2.16 | $2.29 | -0.08% |
| Jul 16 | $2.02 | $2.16 | $2.31 | -0.11% |
| Jul 17 | $2.00 | $2.16 | $2.32 | -0.13% |
| Jul 18 | $1.99 | $2.16 | $2.34 | -0.16% |
| Jul 19 | $1.97 | $2.16 | $2.35 | -0.19% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $1.97 | $2.16 | $2.35 | -0.19% |
| Week 2 | $1.90 | $2.15 | $2.44 | -0.37% |
| Week 3 | $1.84 | $2.15 | $2.50 | -0.56% |
| Week 4 | $1.80 | $2.14 | $2.56 | -0.74% |
| Week 5 | $1.76 | $2.14 | $2.61 | -0.93% |
| Week 6 | $1.72 | $2.14 | $2.65 | -1.11% |
| Week 7 | $1.69 | $2.13 | $2.69 | -1.30% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Intelligent Bio Solutions Inc. is a medical technology company focused on developing and delivering non-invasive testing, and screening solutions in Asia Pacific, the United States, the United Kingdom, and internationally.
The company operates intelligent fingerprinting drug screening system, a platform to analyze fingerprint sweat analysis to detect drugs abuse; and biosensor platform.
The company was formerly known as GBS Inc. and changed its name to Intelligent Bio Solutions Inc. in October 2022. Intelligent Bio Solutions Inc. was incorporated in 2016 and is headquartered in New York, New York.
Intelligent Bio Solutions Inc. (INBS) currently trades at $2.15 per share.
The company has a market capitalization of $5.14M and is ranked 5315.
Near-term forecasts show a cautious path with average prices around $2.15 in 2026, then $2.01 in 2027, $1.99 in 2028, and $1.77 in 2029, before returning to $2.15 in 2030.
Longer-term forecasts point to upside in later years, with 2033, 2040, and 2050 showing stronger averages of $2.88, $3.58, and $4.68 respectively, and max prices reaching $4.99, $7.01, and $10.28 in those years.
A major floor 13.3% below — a decisive break under it would weaken the trend.
Price is testing support right now (0.5% away) — a key level to hold.
The nearest ceiling, 19.0% above — a clean break opens room to run.
A major ceiling 103.2% above — clearing it would confirm fresh momentum.
Key INBS support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of INBS market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $2.21 | Sell | $2.20 | Sell |
| MA 10 | $2.23 | Sell | $2.22 | Sell |
| MA 20 | $2.26 | Sell | $2.29 | Sell |
| MA 50 | $2.55 | Sell | $2.61 | Sell |
| MA 100 | $3.01 | Sell | $3.63 | Sell |
| MA 200 | $5.97 | Sell | $6.62 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 39.65 | Neutral |
| Stoch RSI (14) | 47.57 | Neutral |
| CCI (20) | -116.98 | Sell |
| Williams %R (14) | -95.65 | Info |
| MACD (12,26,9) | 0.01 | Buy |
| ROC (12) | -5.88 | Sell |
| Bollinger %B (20,2) | 0.14 | Neutral |
| Stochastic %K (14) | 4.35 | Buy |
| TRIX (15) | -0.67 | Sell |
| Awesome (5,34) | -0.15 | Sell |
| Ultimate (7,14,28) | 33.59 | Neutral |
| Momentum (10) | 0.01 | Buy |
| Aroon Osc (25) | -56.00 | Sell |
| Hull MA (9) | 2.18 | Sell |
| ADX (14) | 19.44 | Neutral |
| ATR (14) | 0.07 | Info |
The 30-day technical picture is BEARISH.
RSI14 is 40. The SMA50 is $2.64 and the SMA200 is $6.66. The stock sits on a support level of $2.15 and faces a resistance at $4.11.
The 30-day price range runs from $1.64 to $2.82, and the annualized volatility is 80%.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $2.15 | $2.16 | $2.66 | 0% | Neutral | |
| $1.58 | $2.03 | $2.77 | -6% | Neutral | |
| $1.55 | $2.06 | $2.94 | -5% | Neutral | |
| $1.38 | $1.88 | $2.78 | -13% | Neutral | |
| $1.55 | $2.17 | $3.30 | +1% | Neutral | |
| $1.72 | $2.47 | $3.85 | +14% | Neutral | |
| $1.75 | $2.56 | $4.08 | +19% | Neutral | |
| $1.87 | $2.80 | $4.55 | +30% | Bullish | |
| $1.71 | $2.62 | $4.33 | +21% | Bullish | |
| $1.57 | $2.45 | $4.12 | +13% | Neutral | |
| $2.15 | $3.66 | $6.61 | +70% | Bullish | |
| $2.50 | $4.98 | $9.95 | +131% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $2.15 | $2.16 | $2.63 | +0.00% |
| August 2026 | $1.80 | $2.14 | $2.62 | -0.92% |
| September 2026 | $1.76 | $2.11 | $2.61 | -1.49% |
| October 2026 | $1.81 | $2.18 | $2.73 | +3.29% |
| November 2026 | $1.80 | $2.18 | $2.76 | +0.13% |
| December 2026 | $1.71 | $2.08 | $2.66 | -4.42% |
Click any year to see its month-by-month INBS forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect INBS to range from $2.15 to $2.66 through 2026. The $2.16 average target implies a 0% move from current prices. A consolidation phase looks the most probable path here.
The INBS price prediction for 2027 points to an average of $2.03 (low $1.58, high $2.77) — a potential decline of -6% on today's $2.16. Price action looks broadly range-bound.
In 2028, INBS is projected to trade between $1.55 and $2.94, averaging $2.06 — a potential decline of -5% from today's $2.16. That is up +2% on the projected 2027 average. A consolidation phase looks the most probable path here.
Intelligent Bio Solutions Inc.'s 2029 outlook centres on $1.88, within a $1.38 to $2.78 range. That is -9% versus the projected 2028 average. That marks a -13% change versus current levels. Price action looks broadly range-bound.
By 2030, INBS could reach as high as $3.30, with a base case around $2.17 and support toward $1.55 — roughly +1% from $2.16. A consolidation phase looks the most probable path here.
Expect INBS to range from $1.72 to $3.85 through 2031. The $2.47 average target implies a +14% move from current prices. That is up +14% on the projected 2030 average. Price action looks broadly range-bound.
The INBS price prediction for 2032 points to an average of $2.56 (low $1.75, high $4.08) — a potential gain of +19% on today's $2.16. A consolidation phase looks the most probable path here.
In 2033, INBS is projected to trade between $1.87 and $4.55, averaging $2.80 — a potential gain of +30% from today's $2.16. That is up +9% on the projected 2032 average. Momentum favours further upside here.
Intelligent Bio Solutions Inc.'s 2034 outlook centres on $2.62, within a $1.71 to $4.33 range. That is -7% versus the projected 2033 average. That marks a +21% change versus current levels. Buyers look set to stay in control over this stretch.
By 2035, INBS could reach as high as $4.12, with a base case around $2.45 and support toward $1.57 — roughly +13% from $2.16. Price action looks broadly range-bound.
Expect INBS to range from $2.15 to $6.61 through 2040. The $3.66 average target implies a +70% move from current prices. That is up +50% on the projected 2035 average. Buyers look set to stay in control over this stretch.
The INBS price prediction for 2050 points to an average of $4.98 (low $2.50, high $9.95) — a potential gain of +131% on today's $2.16. Momentum favours further upside here.
Investing $1,000 in INBS today (≈ 462.962963 INBS) could be worth
$2,305.05
+$1,305.05 (+131%) by 2050 · US Dollar
Based on the average projected INBS price of $4.98 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in INBSwould be worth at today's price.
$1,000 invested in INBS on Jul 10, 2025 (≈ 54.644811 INBS) would be worth
$118.03
-$881.97 (-88.2%) today · 0.12× · US Dollar
Based on a INBS entry price of $18.3 vs. today's $2.16.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $2.24 | $964.29 | -3.6% |
| 1 month ago | $2.35 | $919.15 | -8.1% |
| 3 months ago | $2.46 | $878.05 | -12.2% |
| 6 months ago | $15.26 | $141.55 | -85.8% |
| 1 year ago | $18.3 | $118.03 | -88.2% |
| All time (5.0y) ago | $8,808 | $0.25 | -100.0% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our INBS forecast.
Our base-case forecast reaches $4.30 around 2050.
Implied market cap at $4.30: $10.28M
The multi-year forecast shows a mixed path with an initial neutral-to-bearish tone in the mid-term, followed by more meaningful upside later. In 2026 the avg price is $2.15 with Neutral sentiment, and by 2029 the avg price is $1.77 with Bearish sentiment, highlighting near-term headwinds.
From 2031 onward the forecast turns more constructive, with 2031 at avg $2.44 (ROI 13.5) and 2032 at avg $2.55 (ROI 18.8). The 2033 forecast shows stronger upside with avg $2.88 (ROI 33.8) and a max $4.99 as sentiment shifts to Bullish.
The longer horizon includes notable upside in 2040 at avg $3.58 (ROI 66.5) and max $7.01, and in 2050 at avg $4.68 (ROI 117.7) and max $10.28, both labeled Bullish. These projections illustrate potential gains in later years, but they come with periods of weaker performance and volatility along the way.
Tap a question to reveal the answer.
The 2030 forecast shows an avg price of $2.15 with a min of $1.45 and a max of $3.45, and an ROI of 0.1%. Sentiment is Neutral. Note: Forecasts are estimates and not guarantees.
Forecasts show Neutral sentiment for 2026 and 2030, with Bearish in 2029 and Bullish in 2033, 2040, and 2050. ROI ranges from -17.8% in 2029 to 117.7% in 2050, indicating mixed and later upside potential. These are estimates, not guarantees.
Yes, the forecast lists a max price of $10.28 in 2050. Other year max prices include $4.99 in 2033 and $7.01 in 2040. These are forward-looking estimates and not guarantees.
Current price is $2.15 and market cap is $5.14M.
The 30-day outlook is bearish with RSI 14 at 40. It shows support at $2.15 and resistance at $4.11, a 30-day range of $1.64 to $2.82, and annualized volatility of 80%.
Intelligent Bio Solutions Inc. Community Discussion
0Share your Intelligent Bio Solutions Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.